Advertisements


Kodiak Sciences Announces Second Quarter 2019 Financial Results and Recent Business Highlights

Kodiak Sciences Announces Second Quarter 2019 Financial Results and Recent Business Highlights.....»»

Category: earningsSource: benzingaAug 14th, 2019

Kodiak Sciences Announces Second Quarter 2019 Financial Results and Recent Business Highlights

Kodiak Sciences Announces Second Quarter 2019 Financial Results and Recent Business Highlights.....»»

Category: earningsSource: benzingaAug 14th, 2019

Kodiak Sciences Announces First Quarter 2019 Financial Results and Recent Business Highlights

PALO ALTO, Calif., M.....»»

Category: earningsSource: benzingaMay 15th, 2019

Kodiak Sciences Announces Third Quarter 2018 Financial Results and Recent Business Highlights

PALO ALTO, Calif., Nov. 16, 2018 /PRNewswire/ -- Kodiak Sciences Inc. (NASDAQ:KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, .....»»

Category: earningsSource: benzingaNov 16th, 2018

Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

MONT-SAINT-GUIBER.....»»

Category: earningsSource: benzingaNov 19th, 2019

Cassava Sciences Announces Recent Clinical Highlights and Third Quarter 2019 Financial Results

Cassava Sciences Announces Recent Clinical Highlights and Third Quarter 2019 Financial Results.....»»

Category: earningsSource: benzingaOct 29th, 2019

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights

MONT-SAINT-GUIBERT, Belgium, May 09, 2019 (GLOBE NEWSWIRE) -- Celyad ((Euronext Brussels and Paris, NA.....»»

Category: earningsSource: benzingaMay 9th, 2019

Oyster Point Pharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights

ZEN Phase 1 top-line data Closed IPO financing and received $92.0 million in gross proceeds PRINCETON, N.J., Dec. 03, 2019 (GLOBE NEWSWIR.....»»

Category: earningsSource: benzingaDec 3rd, 2019

Prevail Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights

Opened Enrollment of PROPEL Phase 1/2 Trial of PR001 to Treat Parkinson's Disease Patients with G.....»»

Category: earningsSource: benzingaNov 12th, 2019

Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments

SOUTH SAN FRANCISCO, Calif., Nov. 8, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ:STRO), a clinical-stage drug discovery, development and .....»»

Category: earningsSource: benzingaNov 8th, 2019

Translate Bio Announces Third Quarter 2019 Financial Results and Reviews Recent Highlights

Translate Bio Announces Third Quarter 2019 Financial Results and Reviews Recent Highlights.....»»

Category: earningsSource: benzingaNov 6th, 2019

Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

– Completed initial public offering, raising $72.0 million in gross proceeds – – Initiated ReDUX4, a Phase 2b clinical trial of losmapimod in FSHD – – Initiated a Phase 2 open label clinical trial of losmapimod in F.....»»

Category: earningsSource: benzingaAug 26th, 2019

Sutro Biopharma Reports Second Quarter 2019 Financial Results and Recent Business Highlights and Developments

SOUTH S.....»»

Category: earningsSource: benzingaAug 14th, 2019

Ardelyx Reports Second Quarter 2019 Financial Results and Recent Business Highlights

Ardelyx Reports Second Quarter 2019 Financial Results and Recent Business Highlights.....»»

Category: earningsSource: benzingaAug 9th, 2019

Ionis Reports Second Quarter 2019 Financial Results

CARLSBAD, Calif., Aug. 7, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today reported its financial results for the second quarter and year-to-date 2019 and recent business highlights. "We ente.....»»

Category: earningsSource: benzingaAug 7th, 2019

Aquestive Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

Aquestive Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights.....»»

Category: earningsSource: benzingaAug 6th, 2019

Trevi Therapeutics Announces First Quarter 2019 Financial Results and Recent Business Developments

Raised $70 Million in Gross Proceeds from Initial Public Offering and Concurrent Private Placement Initiated Phas.....»»

Category: earningsSource: benzingaJun 13th, 2019

HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights

NEW YORK and VIENNA, Austria, May 20, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. ("HOOKIPA"), a company developing a new class of immunotherapeutics, t.....»»

Category: earningsSource: benzingaMay 20th, 2019

Outlook Therapeutics Provides Business Update and Reports Second Quarter Financial Results for Fiscal 2019

CRANBURY, N.J., May 15, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the "Company") today reported business highlights and financial results for its second fiscal quarter ended March 31, 2019. Recent Highlights: FDA acceptance and.....»»

Category: earningsSource: benzingaMay 15th, 2019

Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights

Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights.....»»

Category: earningsSource: benzingaMay 8th, 2019

Translate Bio Announces Fourth Quarter and Full Year 2018 Financial Results and Reviews Recent Highlights

LEXINGTON, Mass., March 21, 2019 (GLOBE NE.....»»

Category: earningsSource: benzingaMar 21st, 2019